Join
Live feed
·
INSIDERFilingvia Quantisnow
United Therapeutics Corporation logo

Amendment: Chairperson & CEO Rothblatt Martine A sold $863,947 worth of shares (1,500 units at $575.96) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 43,153 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
UTHR· United Therapeutics Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track UTHR (United Therapeutics Corporation) and more on Quantisnow.